The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective by Onder Onen, Fusun Gulizar Varol

Subjects: Get full text

Optimizing Subchannel Assignment and Power Allocation for Network Slicing in High-Density NOMA Networks: A Q-Learning Approach by Suhare Solaiman

Subjects: Get full text

hs $$ \mathfrak{hs} $$ -extended gravity from the IKKT matrix model by Alessandro Manta, Harold C. Steinacker, Tung Tran

Subjects: “…M(atrix) Theories…”
Get full text

Using the modified frailty index as a predictor of complications in adults undergoing transforaminal interbody lumbar fusion by Momin M. Mohis, Simon G. Ammanuel, Cuong P. Luu, James A. Stadler

Subjects: Get full text

Charge transport optimisation in SnO2 nanoparticles via Zn doping to achieve a power factor of 83 μW/m.K2 by Najaf Abbas Khan, A. Ali, K. Mahmood, Muhammad Isram, S. Ikram

“…Different concentrations of Zn atoms (x = 0.05 M, 0.1 M, 0.15 M, and 0.20 M) doped in SnO2 to control the carrier concentration and mobility for the optimized value of power factor. …”
Get full text

TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial by Wei Gao, Ping Hu, Aung Naing, Meredith McKean, Anthony Tolcher, Lillian L Siu, Keyvan Tadjalli-Mehr, Anja Victor, Emilia Richter, Marco A F Nogueira Filho, Thomas Kitzing, Stephan Gleicher, Daniel Holland

“…Bintrafusp alfa (BA) is a bifunctional fusion protein that simultaneously blocks nonredundant immunosuppressive TGF-β and PD-(L)1 pathways.Methods This first-in-human, dose-escalation study in patients with advanced solid tumors (N=58; aged ≥18 years, ECOG PS≤1) evaluated M6223 alone (Part 1A, n=40; M6223 10–2400 mg every 2 weeks, n=32; M6223 2400 mg every 3 weeks, n=8) or with BA (Part 1B, n=18; M6223 300–1600 mg with BA 1200 mg; both every 2 weeks, intravenous). …”
Get full text

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma by V. V. Petkau, G. A. Tsaur, E. N. Bessonova, A. A. Karimova

“…NAFLD patients with PNPLA3 I148M polymorphism have a significantly higher chance of developing LC and HCC. …”
Get full text

Ginsenoside Rg1 alleviates chronic testicular damage caused by cranial irradiation through the SCF/PI3K/Akt/mTOR pathway in mice by Qiuhua Zhou, Yiquan Ou, Xiangsheng Tian, Yujun Ning, Yuwei Mao, Weichao Zhao, Dingxin Long

Subjects: Get full text

Geological characteristics of deep coal rock and main geological factors controlling coalbed methane enrichment: a case study of the M area in the eastern Ordos Basin by Xiaojiao GUO, Lei WANG, Xianzhou YAO, Xu LI, Linke ZHANG, Xiaoshuang WANG

“…Favorable exploration areas for deep CBM include regions with coal seams thicker than 6 m, areas with developed fractures far from fault zones (fault displacement less than 5 m), and microstructure high points. …”
Get full text

Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C by M. V. Mayevskaya

Get full text

CircHIPK2 recruits SRSF1 to increase TXNIP mRNA stability and promotes autophagy-dependent ferroptosis and apoptosis in myocardial ischemia-reperfusion injury by Zhu Zhang, Jinqi Hao, Qinghong Qiao, Junting Song, Yanqin Yu

“…RIP and ChIP assays verified the relationship between circHIPK2, SRSF1 and TXNIP. TXNIP mRNA stability was dertermined by actinomycin D. …”
Get full text